Defined gene sets
Hotspot, breast, colorectal, and lung panels interrogate intended regions rather than an undifferentiated genome.
Molecular methods
Patient Test Solutions, Inc is organized around two clinical disciplines: molecular diagnostics by nucleic-acid amplification, and targeted next-generation sequencing. Both are performed and reported by this laboratory.
Molecular diagnostics
Respiratory, COVID-19, urinary tract, and HPV testing are run as multiplex molecular methods. The goal is a clinically useful panel from a single specimen — influenza with SARS-CoV-2, high-risk HPV with genotype resolution, common uropathogens from urine.
Where the chemistry allows, extraction-free workflows shorten the path from specimen to result without sending the case to a second laboratory.
Next-generation sequencing
NGS here is a clinical service of Patient Test Solutions, Inc. Libraries are prepared on site. Interpretation stays with this laboratory.
Hotspot, breast, colorectal, and lung panels interrogate intended regions rather than an undifferentiated genome.
Cell-free DNA library preparation for liquid-biopsy specimens when tissue is limited or follow-up is from blood.
Genomic DNA, FFPE, and cell-free DNA are accepted according to the current requisition.